These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3099781)

  • 1. Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins.
    Blough HA; Pauwels R; De Clercq E; Cogniaux J; Sprecher-Goldberger S; Thiry L
    Biochem Biophys Res Commun; 1986 Nov; 141(1):33-8. PubMed ID: 3099781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-deoxy-D-glucose as a potential drug against fusogenic viruses including HIV.
    Parris GE
    Med Hypotheses; 2008; 70(4):776-82. PubMed ID: 17920779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
    Pal R; Hoke GM; Sarngadharan MG
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of nucleoside diphosphate derivatives of 2-deoxy-D-glucose with the glycosylation of virus-specific glycoproteins in vivo.
    Schmidt MF; Schwarz RT; Scholtissek C
    Eur J Biochem; 1976 Nov; 70(1):55-62. PubMed ID: 1034557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual effects of 2-deoxyglucose on synthesis of the glycoprotein hormone common alpha-subunit in butyrate-treated HeLa cells.
    Cox GS; McClure DS; Cosgrove DE
    Mol Cell Biol; 1987 May; 7(5):1592-601. PubMed ID: 3600639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human retroviral env and gag polypeptides: serologic assays to measure infection.
    Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS
    J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
    McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
    J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactive laser cytometric analysis of retroviral protein expression in HIV-infected lymphocytic cell lines.
    Warren JT; McMahon JB; Weislow OS; Gulakowski RJ; Kiser RF; Boyd MR
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1131-7. PubMed ID: 2265028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of glycosylation reverse retroviral interference.
    Rein A; Schultz AM; Bader JP; Bassin RH
    Virology; 1982 May; 119(1):185-92. PubMed ID: 6280382
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 2-deoxy-D-glucose on cytomegalovirus-induced DNA synthesis in human fibroblasts.
    Radsak KD; Weder D
    J Gen Virol; 1981 Nov; 57(Pt 1):33-42. PubMed ID: 6275020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.
    Montefiori DC; Robinson WE; Mitchell WM
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9248-52. PubMed ID: 3264072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses.
    Zarling JM; Morton W; Moran PA; McClure J; Kosowski SG; Hu SL
    Nature; 1986 Sep 25-Oct 1; 323(6086):344-6. PubMed ID: 3093891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of 2-deoxy-D-glucose on surface glycoproteins of normal and transformed cells.
    Steiner MR; Richards CS
    Cancer Lett; 1983 Jul; 19(3):333-42. PubMed ID: 6309366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
    Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biogenesis of vaccinia. Effects of inhibitors of glycosylation on virus-mediated activities.
    Weintraub S; Stern W; Dales S
    Virology; 1977 May; 78(1):315-22. PubMed ID: 860407
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
    Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the multiplication of enveloped viruses by glucose derivatives.
    Scholtissek C
    Curr Top Microbiol Immunol; 1975; 70():101-19. PubMed ID: 808397
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine.
    Chandra P; Sarin PS
    Arzneimittelforschung; 1986 Feb; 36(2):184-6. PubMed ID: 3008768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
    Schulte C; Meurer M; Fröschl M
    Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.